Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases

Current Medicinal Chemistry

Volumn 16, Issue 25, 2009, Pages 3294-3321

  Tóth, András ^a   Kiss, Loránd ^b   Varró, András ^a,c   Nánási, Péter P ^d  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Arrhythmia; Heart failure; Ischemia reperfusion; KB R794; NCX inhibition; SEA0400

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; 3,4 DIHYDROQUINAZOLINONE DERVATIVE; AMILORIDE DERVATIVE; BENZYLOXYPHENYL DERIVATIVE INHIBITOR; CALCIUM; CARDIOVASCULAR AGENT; PHENOXYPYRIDINE DERVATIVE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SN 6; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN INHIBITOR; UNCLASSIFIED DRUG; YM 244769;

ACIDOSIS; ANTIARRHYTHMIC ACTIVITY; BINDING AFFINITY; CALCIUM BALANCE; CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL HYPOXIA; CELL ISOLATION; CONGESTIVE HEART FAILURE; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG RESPONSE; DRUG STRUCTURE; GENE MUTATION; GENETIC MANIPULATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; INOTROPISM; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPERFUSION INJURY; REVIEW; STRUCTURE ANALYSIS; STUNNED HEART MUSCLE;

ANILINE COMPOUNDS; ANIMALS; HEART DISEASES; HUMANS; MOLECULAR STRUCTURE; PHENYL ETHERS; SODIUM-CALCIUM EXCHANGER; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; THIOUREA;

EID: 70450218941     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788803268     Document Type: Review

References (308)

1. Reuter, H.; Seitz, N. The ionic dependence of calcium efflux from guinea pig auricles. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol., 1968, 259, 190.
2. 2+ exchanger. Ion Pumps "Advances in Molecular & Cell Biology" Life Sciences Program, JAI Press Inc 1998; pp. 309-356.
3. 2+ homeostasis. J. Bioenerg. Biomembr., 1998, 30, 151-160.
4. Blaustein, M.P.; Lederer, W.J. Sodium/calcium exchange: its physiological implications. Physiol. Rev., 1999, 79, 763-854.
5. Egger, M.; Niggli, E. Regulatory function of Na-Ca exchange in the heart: milestones and outlook. J. Membr. Biol., 1999, 168, 107-130. (Pubitemid 29152971)
6. Philipson, K.D.; Nicoll, D.A. Sodium-calcium exchange: a molecular perspective. Annu. Rev. Physiol., 2000, 62, 111-133.
7. Hryshko, L.V. Handbook of Physiology. Oxford University Press: New York, NY, 2001.
8. 2+ exchange in the regulation of cardiac excitation-contraction coupling. Cardiovasc. Res., 2005, 67, 198-207.
9. Kofuji, P.; Lederer, W.J.; Schulze, D.H. Mutually exclusive and cassette exons underlie alternatively spliced isoforms of the Na/Ca exchanger. J. Biol. Chem., 1994, 269, 5145-5149.
10. 2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am. J. Physiol., 1997, 272, C1250-1261.
11. 2+ exchanger in rat astrocytes and neurons by PKA. J. Neurosci., 1998, 18, 4833-4841.
12. Durkin, J.T.; Ahrens, D.C.; Pan, Y.C.; Reeves, J.P. Purification and amino-terminal sequence of the bovine cardiac sodium-calcium exchanger: evidence for the presence of a signal sequence. Arch. Biochem. Biophys., 1991, 290, 369-375.
13. 2+ exchanger. Biochim. Biophys. Acta, 1993, 1151, 35-42.
14. Schwarz, E.M.; Benzer, S. Calx, a Na-Ca exchanger gene of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA, 1997, 94, 10249-10254. (Pubitemid 27407027)
15. 2+ transport. Biochem. J., 2007, 406, 365-382.
16. 2+ exchanger. J. Biol. Chem., 1999, 274, 910-917.
17. 2+ exchanger. Science, 1990, 250, 562-565.
18. 2+ exchanger. J. Biol. Chem., 1991, 266, 1014-1020.
19. 2+ binding motif. J. Biol. Chem., 2006, 281, 21577-21581.
20. 2+ exchanger is essential for regulation: crystal structures and mutational analysis. Proc. Natl. Acad. Sci. USA, 2007, 104, 18467-18472.
21. 2+ sensors. Mol. Cell., 2006, 22, 15-25.
22. 2+ exchange system. Biochemistry, 1990, 29, 2437-2442.
23. 2+ exchanger. Nature, 1991, 352, 715-718.
24. Pitts, B.J. Stoichiometry of sodium-calcium exchange in cardiac sarcolemmal vesicles. Coupling to the sodium pump. J. Biol. Chem., 1979, 254, 6232-6235.
25. 2+ exchange in inside-out patches excised from guinea-pig ventricular myocytes. J. Physiol., 2000, 523(Pt 2), 339-351.
26. 2+ exchanger NCX1.1 measured in transfected HEK cells. Biophys. J., 2002, 82, 1943-1952.
27. Kimura, J.; Miyamae, S.; Noma, A. Identification of sodiumcalcium exchange current in single ventricular cells of guinea-pig. J. Physiol., 1987, 384, 199-222. (Pubitemid 17026516)
28. Chapman, R.A.; Coray, A.; McGuigan, J.A. Sodium/calcium exchange in mammalian ventricular muscle: a study with sodium-sensitive micro-electrodes. J. Physiol., 1983, 343, 253-276.
29. Hilgemann, D.W. Cytoplasmic ATP-dependent regulation of ion transporters and channels: mechanisms and messengers. Annu. Rev. Physiol., 1997, 59, 193-220.
30. Matsuoka, S.; Hilgemann, D.W. Steady-state and dynamic properties of cardiac sodium-calcium exchange. Ion and voltage dependencies of the transport cycle. J. Gen. Physiol., 1992, 100, 963-1001.
31. 2+ concentration jump. Biophys. J., 1996, 71, 2473-2485.
32. Bers, D.M. Excitation-Contraction Coupling and Cardiac Contractile Force. 2nd ed. Dordrecht, Netherlands: Kluwer Academic Press 2001.
33. Grantham, C.J.; Cannell, M.B. Ca2+ influx during the cardiac action potential in guinea pig ventricular myocytes. Circ. Res., 1996, 79, 194-200. (Pubitemid 26255870)
34. duBell, W.H.; Boyett, M.R.; Spurgeon, H.A.; Talo, A.; Stern, M.D.; Lakatta, E.G. The cytosolic calcium transient modulates the action potential of rat ventricular myocytes. J. Physiol., 1991, 436, 347-369.
35. Bers, D.M.; Weber, C.R. Na/Ca exchange function in intact ventricular myocytes. Ann. N Y Acad. Sci., 2002, 976, 500-512. (Pubitemid 36126939)
36. Despa, S.; Brette, F.; Orchard, C.H.; Bers, D.M. Na/Ca exchange and Na/K-ATPase function are equally concentrated in transverse tubules of rat ventricular myocytes. Biophys. J., 2003, 85, 3388-3396.
37. Luo, C.H.; Rudy, Y. A dynamic model of the cardiac ventricular action potential. I: simulations of ionic currents and concentration changes. Circ. Res., 1994, 74, 1071-1096. (Pubitemid 24176903)
38. Noble, D.; Noble, S.J.; Bett, G.C.; Earm, Y.E.; Ho, W.K.; So, I.K. The role of sodium-calcium exchange during the cardiac action potential. Ann. N Y Acad. Sci., 1991, 639, 334-353.
39. 2+ exchange current in the ferret ventricular action potential. J. Physiol., 1997, 498(Pt 3), 611-625.
40. Faber, G.M.; Rudy, Y. Action potential and contractility changes in. [Na(+)] (i) overloaded cardiac myocytes: a simulation study. Biophys. J., 2000, 78, 2392-2404. (Pubitemid 30313797)
41. Armoundas, A.A.; Hobai, I.A.; Tomaselli, G.F.; Winslow, R.L.; O'Rourke, B. Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ. Res., 2003, 93, 46-53. (Pubitemid 36859040)
42. 2+ exchange current. Circ. Res., 2003, 92, 950-952.
43. 2+ management in cardiac myocytes. Ann. N Y Acad. Sci., 2004, 1015, 28-38.
44. Greenstein, J.L.; Hinch, R.; Winslow, R.L. Mechanisms of excitation-contraction coupling in an integrative model of the cardiac ventricular myocyte. Biophys. J., 2006, 90, 77-91.
45. 2+ dynamics in ventricular myocytes. Prog. Biophys. Mol. Biol., 2008, 96, 377-398.
46. 2+ exchange current in isolated toad pacemaker cells. J. Physiol., 1998, 508(Pt 1), 153-166.
47. 2+ release contributes to automaticity in cat atrial pacemaker cells. J. Physiol., 2000, 524(Pt 2), 415-422.
48. Rigg, L.; Heath, B.M.; Cui, Y.; Terrar, D.A. Localisation and functional significance of ryanodine receptors during beta-adrenoceptor stimulation in the guinea-pig sino-atrial node. Cardiovasc. Res., 2000, 48, 254-264.
49. 2+) exchanger: molecular partners in pacemaker regulation. Circ. Res., 2001, 88, 1254-1258.
50. 2+) release during diastolic depolarization to accelerate pacemaker activity in rabbit sinoatrial nodal cells. Circ. Res., 2002, 90, 73-79.
51. Bucchi, A.; Baruscotti, M.; Robinson, R.B.; DiFrancesco, D. I(f)-dependent modulation of pacemaker rate mediated by cAMP in the presence of ryanodine in rabbit sino-atrial node cells. J. Mol. Cell. Cardiol., 2003, 35, 905-913.
52. 2+ exchanger. Nature, 2004, 427, 544-548.
53. 2+ exchange for the pacemaking mechanism in guinea-pig sino-atrial node. J. Physiol., 2006, 571, 639-649.
54. Allen, T.J. The effects of manganese and changes in internal calcium on Na-Ca exchange fluxes in the intact squid giant axon. Biochim. Biophys. Acta., 1990, 1030, 101-110.
55. 2+ inflow via Na/Ca exchange in squid axon. Nature, 1985, 315, 755-756.
56. DiPolo, R. Calcium influx in internally dialyzed squid giant axons. J. Gen. Physiol., 1979, 73, 91-113. (Pubitemid 9089689)
57. 2+o-Na+i and Na+o-Na+i exchanges in the absence of Ca chelating agents. Biochim. Biophys. Acta, 1989, 978, 328-332.
58. 2+ exchange current in guinea-pig ventricular myocytes. J. Physiol., 2000, 529(Pt 3), 611-623.
59. Miura, Y.; Kimura, J. Sodium-calcium exchange current: dependence on internal Ca and Na and competitive binding of external Na and Ca. J. Gen. Physiol., 1989, 93, 1129-1145. (Pubitemid 19166595)
60. 2+ and Ba2+. J. Gen. Physiol., 1997, 109, 361-369.
61. Condrescu, M.; Chernaya, G.; Kalaria, V.; Reeves, J.P. Barium influx mediated by the cardiac sodium-calcium exchanger in transfected Chinese hamster ovary cells. J. Gen. Physiol., 1997, 109, 41-51. (Pubitemid 27030192)
62. 2+)] during the cardiac action potential. Circ. Res., 2002, 90, 182-189.
63. Doering, A.E.; Lederer, W.J. The mechanism by which cytoplasmic protons inhibit the sodium-calcium exchanger in guinea-pig heart cells. J. Physiol., 1993, 466, 481-499.
64. Espinosa-Tanguma, R.; DeSantiago, J.; Rasgado-Flores, H. Alpha-chymotrypsin deregulation of the sodium-calcium exchanger in barnacle muscle cells. Am. J. Physiol., 1993, 265, C1118-1127. (Pubitemid 2006318)
65. Blaustein, M.P.; Santiago, E.M. Effects of internal and external cations and of ATP on sodium-calcium and calcium-calcium exchange in squid axons. Biophys. J., 1977, 20, 79-111.
66. 2+i-dependent phosphorylation. Biochim. Biophys. Acta., 1987, 897, 347-354.
67. 2+ exchange and KATP potassium channels by PIP2. Science, 1996, 273, 956-959.
68. 2+ exchanger by insulin. Mol. Cell. Biochem., 1994, 135, 113-119.
69. 2+ exchanger by phenylephrine, angiotensin II and endothelin 1. J. Mol. Cell. Cardiol., 1996, 28, 11-17.
70. Ginsburg, K.S.; Bers, D.M. Isoproterenol does not enhance Ca-dependent Na/Ca exchange current in intact rabbit ventricular myocytes. J. Mol. Cell. Cardiol., 2005, 39, 972-981.
71. Chen, Z.; Jones, L.R.; O'Brian, J.J.; Moorman, J.R.; Cala, S.E. Structural domains in phospholemman: a possible role for the carboxyl terminus in channel inactivation. Circ. Res., 1998, 82, 367-374.
72. Bossuyt, J.; Despa, S.; Martin, J.L.; Bers, D.M. Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump. J. Biol. Chem., 2006, 281, 32765-32773.
73. 2+)] (i) transients in adult rat myocytes. Am. J. Physiol. Heart Circ. Physiol., 2002, 283, H1616-1626.
74. 2+ content in adult rat myocytes. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, H2079-2088.
75. Seidler, T.; Miller, S.L.; Loughrey, C.M.; Kania, A.; Burow, A.; Kettlewell, S.; Teucher, N.; Wagner, S.; Kogler, H.; Meyers, M.B.; Hasenfuss, G.; Smith, G.L. Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes. Circ. Res., 2003, 93, 132-139.
76. 2+) exchanger expression and function in a rabbit model of myocardial infarction. J. Cardiovasc. Electrophysiol., 2006, 17(Suppl 1), S57-S63.
77. Schulze, D.H.; Muqhal, M.; Lederer, W.J.; Ruknudin, A.M. Sodium/calcium exchanger (NCX1) macromolecular complex. J. Biol. Chem., 2003, 278, 28849-28855.
78. 2+ exchange in sarcolemma vesicles and cultured cells from chick heart. Biochim. Biophys. Acta., 1981, 645, 311-317.
79. 2+ exchange in cardiac sarcolemmal vesicles. Biochim. Biophys. Acta., 1983, 731, 63-68.
80. 2+ exchanger isoforms NCX1 and NCX3 does not require their direct phosphorylation. Biochemistry, 1998, 37, 17230-17238.
81. 2+ exchange current in guinea pig cardiac ventricular myocytes. Jpn. J. Pharmacol., 2002, 90, 21-27.
82. Yatani, A.; Brown, A.M.; Schwartz, A. Bepridil block of cardiac calcium and sodium channels. J. Pharmacol. Exp. Ther., 1986, 237, 9-17. (Pubitemid 16116336)
83. Cohen, C.J.; Spires, S.; Van Skiver, D. Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J. Gen. Physiol., 1992, 100, 703-728.
84. Wang, J.C.; Kiyosue, T.; Kiriyama, K.; Arita, M. Bepridil differentially inhibits two delayed rectifier K(+) currents, I(Kr) and I(Ks), in guinea-pig ventricular myocytes. Br. J. Pharmacol., 1999, 128, 1733-1738. (Pubitemid 30011887)
85. Berger, F.; Borchard, U.; Hafner, D. Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres. Naunyn Schmiedebergs Arch. Pharmacol., 1989, 339, 638-646. (Pubitemid 19159821)
86. Hara, Y.; Nakaya, H. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor operated potassium current in guinea-pig atrial cells. Br. J. Pharmacol., 1995, 116, 2750-2756.
87. Mori, K.; Kobayashi, S.; Saito, T.; Masuda, Y.; Nakaya, H. Inhibitory effects of class I and IV antiarrhythmic drugs on the Na+-activated K+ channel current in guinea pig ventricular cells. Naunyn Schmiedebergs Arch. Pharmacol., 1998, 358, 641-648. (Pubitemid 28563767)
88. Horie, M.; Hayashi, S.; Yuzuki, Y.; Sasayama, S. Comparative studies of ATP sensitive potassium channels in heart and pancreatic beta cells using Vaughan-Williams class Ia antiarrhythmics. Cardiovasc. Res., 1992, 26, 1087-1094.
89. Sato, T.; Wu, B.; Kiyosue, T.; Arita, M. Effects of cibenzoline, a new class Ia antiarrhythmic drug, on various membrane ionic currents and action potentials of guinea-pig ventricular cells. Naunyn Schmiedebergs Arch. Pharmacol., 1994, 350, 167-173. (Pubitemid 24248376)
90. 2+ exchanger. Ann. N Y Acad. Sci., 2002, 976, 513-519.
91. Holmstedt, B. Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol. Rev., 1959, 11, 567-688.
92. Chin, T.K.; Spitzer, K.W.; Philipson, K.D.; Bridge, J.H. The effect of exchanger inhibitory peptide (XIP) on sodium-calcium exchange current in guinea pig ventricular cells. Circ. Res., 1993, 72, 497-503.
93. Hobai, I.A.; Maack, C.; O'Rourke, B. Partial inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure. Circ. Res., 2004, 95, 292-299. (Pubitemid 39056290)
94. 2+ exchange blockers in the treatment of cardiac disease. Expert Opin. Investig. Drugs., 2004, 13, 653-664.
95. 2+ exchanger in cerebral ischemia induced by middle cerebral artery occlusion in male rats. Neuropharmacology, 2004, 46, 439-448.
96. Hiller, R.; Shpak, C.; Shavit, G.; Shpak, B.; Khananshvili, D. An unknown endogenous inhibitor of Na/Ca exchange can enhance the cardiac muscle contractility. Biochem. Biophys. Res. Commun., 2000, 277, 138-146. (Pubitemid 30796352)
97. Shpak, C.; Hiller, R.; Shpak, B.; Boyman, L.; Khananshvili, D. The low molecular weight inhibitor of NCX1 interacts with a cytosolic domain that differs from the ion-transport site of the Na/Ca exchanger. Biochem. Biophys. Res. Commun., 2004, 324, 1346-1351. (Pubitemid 40292170)
98. Boyman, L.; Hiller, R.; Shpak, B.; Yomtov, E.; Shpak, C.; Khananshvili, D. Advanced procedures for separation and analysis of low molecular weight inhibitor (NCXIF) of the cardiac sodiumcalcium exchanger. Biochem. Biophys. Res. Commun., 2005, 337, 936-943. (Pubitemid 41447004)
99. 2+ exchanger blocks the ion transport without preventing the binding of either sodium or calcium. Biochemistry, 1996, 35, 15933-15940.
100. 2+ exchange in cells expressing NCX1. J. Biol. Chem., 1996, 271, 22391-22397.
101. 2+ exchange current in guinea-pig cardiac ventricular cells. Br. J. Pharmacol., 1996, 119, 555-563.
102. 2+ exchange inhibitor. Cardiovasc. Drug. Rev., 2003, 21, 255-276.
103. 2+ uniporter. Br. J. Pharmacol., 2007, 151, 647-654.
104. 2+ exchange inhibitor KB-R7943 potently blocks TRPC channels. Biochem. Biophys. Res. Commun., 2007, 361, 230-236.
105. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J. Pharmacol. Exp. Ther., 2001, 298, 249-256.
106. 2+) exchanger. J. Pharmacol. Sci., 2005, 97, 339-343.
107. Tanaka, H.; Nishimaru, K.; Aikawa, T.; Hirayama, W.; Tanaka, Y.; Shigenobu, K. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br. J. Pharmacol., 2002, 135, 1096-1100. (Pubitemid 34259108)
108. 2+ current in canine ventricular cardiomyocytes. Naunyn Schmiedebergs Arch. Pharmacol., 2005, 372, 63-70.
109. 2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl] thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative. Mol. Pharmacol., 2004, 66, 45-55.
110. 2+ exchange inhibitors. Mol. Cell. Biochem., 2004, 259, 157-161.
111. Kuramochi, T.; Kakefuda, A.; Yamada, H.; Tsukamoto, I.; Taguchi, T.; Sakamoto, S. Discovery of an N-(2-aminopyridin-4-ylmethyl)nicotinamide derivative: a potent and orally bioavailable NCX inhibitor. Bioorg. Med. Chem., 2005, 13, 4022-4036. (Pubitemid 40725034)
112. 2+ exchange inhibitor that preferentially inhibits NCX3, efficiently protects against hypoxia/reoxygenation-induced SH-SY5Y neuronal cell damage. Mol. Pharmacol., 2006, 70, 2075-2083.
113. 2+ exchange (NCX1) inhibition by SEA0400. J. Biol. Chem., 2004, 279, 7544-7553.
114. 2+ exchangers with altered ionic regulation. Mol. Pharmacol., 2004, 65, 802-810.
115. 2+ exchanger, NCX1.1. J. Pharmacol. Exp. Ther., 2004, 311, 748-757.
116. 2+ exchanger. Circulation, 2006, 114, I226-232.
117. 2+) or Li(+). J. Biol. Chem., 1999, 274, 23094-23102.
118. Reeves, J.P.; Bailey, C.A.; Hale, C.C. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J. Biol. Chem., 1986, 261, 4948-4955.
119. 2+ exchanger in C6 glioma cells. J. Neurochem., 2000, 74, 1505-1513.
120. 2+) exchanger. J. Biol. Chem., 2000, 275, 182-188.
121. 2+ exchanger by DEPC. Ann. N Y Acad. Sci., 2002, 976, 85-88.
122. Shipston, M.J.; Armstrong, D.L. Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumour cells. J. Physiol., 1996, 493(Pt 3), 665-672.
123. 2+ exchange in rat ventricular myocytes. Cardiovasc. Res., 1998, 38, 703-710.
124. Eriksson, K.S.; Sergeeva, O.; Brown, R.E.; Haas, H.L. Orexin/hypocretin excites the histaminergic neurons of the tubero-mammillary nucleus. J. Neurosci., 2001, 21, 9273-9279. (Pubitemid 33096871)
125. 2+)-exchange. Neuropharmacology, 2001, 40, 345-351.
126. 2+) exchanger by beta-adrenergic signaling pathway in shark ventricular myocytes. Proc. Natl. Acad. Sci. USA, 2001, 98, 2023-2028.
127. 2+ exchange in heart sarcolemma by insulin. Life Sci., 1986, 39, 1077-1083.
128. 2+ exchange by concanavalin A. Biochem. Biophys. Res. Commun., 1988, 154, 245-251.
129. Rogister, F.; Laeckmann, D.; Plasman, P.; Van Eylen, F.; Ghyoot, M.; Maggetto, C.; Liegeois, J.; Geczy, J.; Herchuelz, A.; Delarge, J.; Masereel, B. Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives. Eur. J. Med. Chem., 2001, 36, 597-614. (Pubitemid 32964731)
130. 2+ exchange. Naunyn Schmiedebergs Arch. Pharmacol., 1991, 344, 220-224.
131. Kuramochi, T.; Kakefuda, A.; Yamada, H.; Sato, I.; Taguchi, T.; Sakamoto, S. Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger. Bioorg. Med. Chem., 2004, 12, 5039-5056. (Pubitemid 39200608)
132. Kuramochi, T.; Kakefuda, A.; Sato, I.; Tsukamoto, I.; Taguchi, T.; Sakamoto, S. Synthesis and structure-activity relationships of 6-{4-[(3-fluorobenzyl)oxy] phenoxy} nicotinamide derivatives as a novel class of NCX inhibitors: a QSAR study. Bioorg. Med. Chem., 2005, 13, 717-724. (Pubitemid 40093614)
133. Kuramochi, T.; Kakefuda, A.; Yamada, H.; Ogiyama, T.; Taguchi, T.; Sakamoto, S. Synthesis and structure-activity relationships of benzyloxyphenyl derivatives as a novel class of NCX inhibitors: effects on heart failure. Bioorg. Med. Chem., 2005, 13, 725-734. (Pubitemid 40093615)
134. 2+ exchanger inhibitor: design, synthesis and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives. Bioorg. Med. Chem. Lett., 2003, 13, 3471-3475.
135. Hasegawa, H.; Muraoka, M.; Ohmori, M.; Matsui, K.; Kojima, A. A novel class of sodium/calcium exchanger inhibitor: design, synthesis, and structure-activity relationships of 3,4-dihydro-2(1H)-quinazolinone derivatives. Bioorg. Med. Chem., 2005, 13, 3721-3735. (Pubitemid 40615925)
136. Koushik, S.V.; Wang, J.; Rogers, R.; Moskophidis, D.; Lambert, N.A.; Creazzo, T.L.; Conway, S.J. Targeted inactivation of the sodium-calcium exchanger (Ncx1) results in the lack of a heartbeat and abnormal myofibrillar organization. FASEB J., 2001, 15, 1209-1211.
137. 2+ exchange. Cell. Calcium, 2003, 34, 19-26.
138. 2+ exchange expression. Biochem. Biophys. Res. Commun., 2004, 322, 1336-1340.
139. 2+ exchange: cardiac-specific knockout of NCX1. Circ. Res., 2004, 95, 604-611.
140. 2+ flux. Circ. Res., 2005, 97, 1288-1295.
141. 2+ exchanger. J. Physiol., 1998, 512(Pt 3), 651-667.
142. 2+ transient and contractility in canine ventricular cardiomyocytes. Cardiovasc. Res., 2008, 78, 476-484.
143. Janvier, N.C.; Boyett, M.R. The role of Na-Ca exchange current in the cardiac action potential. Cardiovasc. Res., 1996, 32, 69-84.
144. Nagy, Z.A.; Virag, L.; Toth, A.; Biliczki, P.; Acsai, K.; Banyasz, T.; Nanasi, P.; Papp, J.G.; Varro, A. Selective inhibition of sodium-calcium exchanger by SEA-0400 decreases early and delayed after depolarization in canine heart. Br. J. Pharmacol., 2004, 143, 827-831. (Pubitemid 39664841)
145. 2+) overload in rat ventricular myocytes. Circulation, 2000, 101, 1441-1446.
146. Miyata, A.; Zipes, D.P.; Hall, S.; Rubart, M. Kb-R7943 prevents acute, atrial fibrillation-induced shortening of atrial refractoriness in anesthetized dogs. Circulation, 2002, 106, 1410-1419. (Pubitemid 35013047)
147. 2+ exchange inhibitor, does not suppress ischemia/reperfusion arrhythmias nor digitalis arrhythmias in dogs. Jpn. J. Pharmacol., 2002, 90, 229-235.
148. 2+) handling in isolated rat ventricular myocytes. Eur. J. Pharmacol., 2007, 576, 1-6.
149. 2+ exchange inhibitor, on myocardial ischemia/reperfusion injury]. Nippon Yakurigaku Zasshi, 1998, 111, 105-115.
150. 2+ exchange inhibitor, KB-R7943 on ouabain-induced arrhythmias in guinea-pigs. Br. J. Pharmacol., 1999, 127, 1846-1850.
151. 2+ transient induced by angiotensin II in isolated adult rabbit ventricular myocytes. Naunyn Schmiedebergs Arch. Pharmacol., 1999, 360, 575-584.
152. 2+ exchanger inhibitor, KB-R7943, caused negative inotropic responses and negative followed by positive chronotropic responses in isolated, blood-perfused dog heart preparations. Jpn. J. Pharmacol., 2000, 82, 155-163.
153. 2+ transient and contractility in rabbit ventricular myocytes: pharmacological analysis with KB-R7943. Br. J. Pharmacol., 1999, 126, 1785-1795.
154. 2+ exchanger, during ischemia and reperfusion in guinea-pig myocardium. Life Sci., 2005, 77, 312-324.
155. 2+ exchange inhibitor, on ventricular arrhythmias in the in vivo dogs. Eur. J. Pharmacol., 2005, 506, 249-255.
156. 2+) exchanger inhibition exerts a positive inotropic effect in the rat heart, but fails to influence the contractility of the rabbit heart. Br. J. Pharmacol., 2008, 154, 93-104.
157. 2+) transients and contractions in Langendorff-perfused guinea pig heart. Naunyn Schmiedebergs Arch. Pharmacol., 2008, 378, 65-71.
158. 2+ load attributable to the predominance of forward mode block. Circ. Res., 2008, 102, 1398-1405.
159. 2+) release cause a triggered arrythmia? Cellular versus tissue requirements. Circ. Res., 2000, 87, 725-727.
160. Janse, M.J. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res., 2004, 61, 208-217.
161. Scoote, M.; Williams, A.J. Myocardial calcium signalling and arrhythmia pathogenesis. Biochem. Biophys. Res. Commun., 2004, 322, 1286-1309.
162. 2+ be antiarrhythmic? Pharmacol. Ther., 2005, 108, 149-179.
163. Ter Keurs, H.E.; Boyden, P.A. Calcium and arrhythmogenesis. Physiol. Rev., 2007, 87, 457-506.
164. Sipido, K.R.; Varro, A.; Eisner, D. Sodium calcium exchange as a target for antiarrhythmic therapy. Handb. Exp. Pharmacol., 2006, 159-199.
165. Kranias, E.G.; Bers, D.M. Calcium and cardiomyopathies. Subcell. Biochem., 2007, 45, 523-537.
166. Rubart, M.; Zipes, D.P. Mechanisms of sudden cardiac death. J. Clin. Invest., 2005, 115, 2305-2315.
167. Pogwizd, S.M.; Bers, D.M. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc. Med., 2004, 14, 61-66. (Pubitemid 38340848)
168. Sipido, K.R. Calcium overload, spontaneous calcium release, and ventricular arrhythmias. Heart Rhythm., 2006, 3, 977-979. (Pubitemid 44103496)
169. Allessie, M.A.; Boyden, P.A.; Camm, A.J.; Kleber, A.G.; Lab, M.J.; Legato, M.J.; Rosen, M.R.; Schwartz, P.J.; Spooner, P.M.; Van Wagoner, D.R.; Waldo, A.L. Pathophysiology and prevention of atrial fibrillation. Circulation, 2001, 103, 769-777.
170. Allessie, M.; Ausma, J.; Schotten, U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res., 2002, 54, 230-246. (Pubitemid 34327903)
171. Nattel, S.; Li, D. Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation. Circ. Res., 2000, 87, 440-447. (Pubitemid 30736735)
172. 2+ waves during triggered propagated contractions in intact trabeculae. Am. J. Physiol., 1998, 274, H266-276.
173. 2+ release. J. Physiol., 1997, 501(Pt 1), 3-16.
174. 2+] i waves in cardiac myocytes. Am. J. Physiol., 1996, 270, C148-159.
175. 2+ current. Circ. Res., 1989, 64, 977-990.
176. 2+ window current. Circ. Res., 1992, 70, 456-464.
177. 2+ release from sarcoplasmic reticulum in guinea pig ventricular myocytes. Circ. Res., 1995, 76, 102-109.
178. Boutjdir, M.; Restivo, M.; Wei, Y.; Stergiopoulos, K.; El-Sherif, N. Early afterdepolarization formation in cardiac myocytes: analysis of phase plane patterns, action potential, and membrane currents. J. Cardiovasc. Electrophysiol., 1994, 5, 609-620. (Pubitemid 24239774)
179. Volders, P.G.; Vos, M.A.; Szabo, B.; Sipido, K.R.; de Groot, S.H.; Gorgels, A.P.; Wellens, H.J.; Lazzara, R. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc. Res., 2000, 46, 376-392. (Pubitemid 30319324)
180. Stengl, M.; Ramakers, C.; Donker, D.W.; Nabar, A.; Rybin, A.V.; Spatjens, R.L.; van der Nagel, T.; Wodzig, W.K.; Sipido, K.R.; Antoons, G.; Moorman, A.F.; Vos, M.A.; Volders, P.G. Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation. Cardiovasc. Res., 2006, 72, 90-100.
181. Bosch, R.F.; Nattel, S. Cellular electrophysiology of atrial fibrillation. Cardiovasc. Res., 2002, 54, 259-269.
182. Nattel, S.; Maguy, A.; Le Bouter, S.; Yeh, Y.H. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol. Rev., 2007, 87, 425-456. (Pubitemid 47084677)
183. Wijffels, M.C.; Kirchhof, C.J.; Dorland, R.; Power, J.; Allessie, M.A. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation, 1997, 96, 3710-3720.
184. Goette, A.; Honeycutt, C.; Langberg, J.J. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation, 1996, 94, 2968-2974.
185. Sun, H.; Chartier, D.; Leblanc, N.; Nattel, S. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc. Res., 2001, 49, 751-761. (Pubitemid 32178378)
186. Brundel, B.J.; Henning, R.H.; Kampinga, H.H.; Van Gelder, I.C.; Crijns, H.J. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc. Res., 2002, 54, 315-324. (Pubitemid 34327911)
187. Gaspo, R.; Bosch, R.F.; Talajic, M.; Nattel, S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation, 1997, 96, 4027-4035. (Pubitemid 27506062)
188. Haissaguerre, M.; Jais, P.; Shah, D.C.; Takahashi, A.; Hocini, M.; Quiniou, G.; Garrigue, S.; Le Mouroux, A.; Le Metayer, P.; Clementy, J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med., 1998, 339, 659-666. (Pubitemid 28402090)
189. Chen, S.A.; Hsieh, M.H.; Tai, C.T.; Tsai, C.F.; Prakash, V.S.; Yu, W.C.; Hsu, T.L.; Ding, Y.A.; Chang, M.S. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation, 1999, 100, 1879-1886.
190. Jais, P.; Hocini, M.; Macle, L.; Choi, K.J.; Deisenhofer, I.; Weerasooriya, R.; Shah, D.C.; Garrigue, S.; Raybaud, F.; Scavee, C.; Le Metayer, P.; Clementy, J.; Haissaguerre, M. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation, 2002, 106, 2479-2485. (Pubitemid 35278805)
191. Blom, N.A.; Gittenberger-de Groot, A.C.; DeRuiter, M.C.; Poelmann, R.E.; Mentink, M.M.; Ottenkamp, J. Development of the cardiac conduction tissue in human embryos using HNK-1 antigen expression: possible relevance for understanding of abnormal atrial automaticity. Circulation, 1999, 99, 800-806. (Pubitemid 29083021)
192. Perez-Lugones, A.; McMahon, J.T.; Ratliff, N.B.; Saliba, W.I.; Schweikert, R.A.; Marrouche, N.F.; Saad, E.B.; Navia, J.L.; McCarthy, P.M.; Tchou, P.; Gillinov, A.M.; Natale, A. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J. Cardiovasc. Electrophysiol., 2003, 14, 803-809. (Pubitemid 36994096)
193. Honjo, H.; Boyett, M.R.; Niwa, R.; Inada, S.; Yamamoto, M.; Mitsui, K.; Horiuchi, T.; Shibata, N.; Kamiya, K.; Kodama, I. Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation, 2003, 107, 1937-1943. (Pubitemid 36444138)
194. Postma, A.V.; Denjoy, I.; Hoorntje, T.M.; Lupoglazoff, J.M.; Da Costa, A.; Sebillon, P.; Mannens, M.M.; Wilde, A.A.; Guicheney, P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ. Res., 2002, 91, e21-26.
195. Mohler, P.J.; Schott, J.J.; Gramolini, A.O.; Dilly, K.W.; Guatimosim, S.; duBell, W.H.; Song, L.S.; Haurogne, K.; Kyndt, F.; Ali, M.E.; Rogers, T.B.; Lederer, W.J.; Escande, D.; Le Marec, H.; Bennett, V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature, 2003, 421, 634-639.
196. Amran, M.S.; Hashimoto, K.; Homma, N. Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies. J. Pharmacol. Exp. Ther., 2004, 310, 83-89. (Pubitemid 38812698)
197. 2+ influx. Eur. J. Pharmacol., 1999, 365, 233-239.
198. 2+ exchange, KB-R7943, on reoxygenation-induced injuries in guinea pig papillary muscles. J. Cardiovasc. Pharmacol., 2000, 35, 121-128.
199. 2+) exchanger. J. Mol. Cell. Cardiol., 2001, 33, 1861-1869.
200. 2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, H1334-1345.
201. 2+ exchanger, on myocardial ischemia-reperfusion injuries. Eur. J. Pharmacol., 2003, 458, 155-162.
202. Sadoshima, J.; Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol., 1997, 59, 551-571. (Pubitemid 27142455)
203. Hefti, M.A.; Harder, B.A.; Eppenberger, H.M.; Schaub, M.C. Signaling pathways in cardiac myocyte hypertrophy. J. Mol. Cell. Cardiol., 1997, 29, 2873-2892.
204. Sugden, P.H. Signaling in myocardial hypertrophy: life after calcineurin? Circ. Res., 1999, 84, 633-646.
205. Molkentin, J.D.; Dorn, G.W.; 2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol., 2001, 63, 391-426.
206. 2+ uptake and release mechanisms. Am. J. Physiol. Heart Circ. Physiol., 2007, 292, H1607-1618.
207. 2+) exchange activity in canine pacing-induced heart failure. Circ. Res., 2000, 87, 690-698.
208. Pogwizd, S.M.; Schlotthauer, K.; Li, L.; Yuan, W.; Bers, D.M. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ. Res., 2001, 88, 1159-1167.
209. 2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ. Res., 2003, 93, 592-594.
210. Marx, S.O.; Reiken, S.; Hisamatsu, Y.; Jayaraman, T.; Burkhoff, D.; Rosemblit, N.; Marks, A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell, 2000, 101, 365-376.
211. Li, L.; Chu, G.; Kranias, E.G.; Bers, D.M. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am. J. Physiol., 1998, 274, H1335-1347.
212. Piacentino, V.; 3rd.; Weber, C.R.; Chen, X.; Weisser-Thomas, J.; Margulies, K.B.; Bers, D.M.; Houser, S.R. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ. Res., 2003, 92, 651-658.
213. O'Rourke, B.; Kass, D.A.; Tomaselli, G.F.; Kaab, S.; Tunin, R.; Marban, E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ. Res., 1999, 84, 562-570. (Pubitemid 29138593)
214. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation, 1999, 99, 641-648.
215. Pieske, B.; Kretschmann, B.; Meyer, M.; Holubarsch, C.; Weirich, J.; Posival, H.; Minami, K.; Just, H.; Hasenfuss, G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation, 1995, 92, 1169-1178.
216. Pogwizd, S.M. Clinical potential of sodium-calcium exchanger inhibitors as antiarrhythmic agents. Drugs, 2003, 63, 439-452.
217. 2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation, 2000, 102, 2137-2144.
218. Sipido, K.R.; Volders, P.G.; Vos, M.A.; Verdonck, F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc. Res., 2002, 53, 782-805. (Pubitemid 34261018)
219. Veldkamp, M.W.; Verkerk, A.O.; van Ginneken, A.C.; Baartscheer, A.; Schumacher, C.; de Jonge, N.; de Bakker, J.M.; Opthof, T. Norepinephrine induces action potential prolongation and early afterdepolarizations in ventricular myocytes isolated from human end-stage failing hearts. Eur. Heart J., 2001, 22, 955-963. (Pubitemid 32625218)
220. 2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure? Cardiovasc. Res., 2005, 68, 204-212.
221. Bryant, S.M.; Shipsey, S.J.; Hart, G. Regional differences in electrical and mechanical properties of myocytes from guinea-pig hearts with mild left ventricular hypertrophy. Cardiovasc. Res., 1997, 35, 315-323. (Pubitemid 27372043)
222. Keung, E.C.; Aronson, R.S. Transmembrane action potentials and the electrocardiogram in rats with renal hypertension. Cardiovasc. Res., 1981, 15, 611-614. (Pubitemid 12196420)
223. Beuckelmann, D.J.; Nabauer, M.; Erdmann, E. Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J. Mol. Cell. Cardiol., 1991, 23, 929-937.
224. Spragg, D.D.; Leclercq, C.; Loghmani, M.; Faris, O.P.; Tunin, R.S.; DiSilvestre, D.; McVeigh, E.R.; Tomaselli, G.F.; Kass, D.A. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation, 2003, 108, 929-932.
225. Vermeulen, J.T.; McGuire, M.A.; Opthof, T.; Coronel, R.; de Bakker, J.M.; Klopping, C.; Janse, M.J. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc. Res., 1994, 28, 1547-1554.
226. Li, D.; Melnyk, P.; Feng, J.; Wang, Z.; Petrecca, K.; Shrier, A.; Nattel, S. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation, 2000, 101, 2631-2638. (Pubitemid 30350643)
227. 2+ exchange to action potential of human atrial myocytes. Am. J. Physiol., 1996, 271, H1151-1161.
228. Gaughan, J.P.; Furukawa, S.; Jeevanandam, V.; Hefner, C.A.; Kubo, H.; Margulies, K.B.; McGowan, B.S.; Mattiello, J.A.; Dipla, K.; Piacentino, V.; 3rd.; Li, S.; Houser, S.R. Sodium/calcium exchange contributes to contraction and relaxation in failed human ventricular myocytes. Am. J. Physiol., 1999, 277, H714-724.
229. 2+) exchanger overexpression predisposes to reactive oxygen species-induced injury. Cardiovasc. Res., 2003, 60, 404-412.
230. 2+]i-independent positive inotropic effects in failing human myocardium. Circulation, 2005, 111, 2588-2595.
231. 2+-dependent positive inotropic effects in failing human myocardium. Circ. Res., 2003, 92, 169-176.
232. Allen, D.G.; Orchard, C.H. The effects of changes of pH on intracellular calcium transients in mammalian cardiac muscle. J. Physiol., 1983, 335, 555-567. (Pubitemid 13148387)
233. 2+ uptake and release by sarcoplasmic reticulum of intact rat ventricular myocytes. Am. J. Physiol., 1998, 275, H977-987.
234. Deitmer, J.W.; Ellis, D. Interactions between the regulation of the intracellular pH and sodium activity of sheep cardiac Purkinje fibres. J. Physiol., 1980, 304, 471-488. (Pubitemid 10034395)
235. Bountra, C.; Vaughan-Jones, R.D. Effect of intracellular and extracellular pH on contraction in isolated, mammalian cardiac muscle. J. Physiol., 1989, 418, 163-187. (Pubitemid 19276926)
236. 2+ exchange in canine cardiac sarcolemmal vesicles. Circ. Res., 1982, 50, 287-293.
237. Reimer, K.A.; Jennings, R.B. The Heart and Cardiovascular System. 2nd ed. Raven press: New York, NY, 1992.
238. Jennings, R.B.; Steenbergen, C.; Jr.; Reimer, K.A. Myocardial ischemia and reperfusion. Monogr. Pathol., 1995, 37, 47-80.
239. Goldhaber, J.I. The Myocardium. 2nd ed. Academic Press: San Diego, CA, 1997.
240. Opie, L.H. The Heart Physiology: From Cell to Circulation. 3rd ed. Lippincott-Raven: Philadelphia, PA, 1998.
241. Haddad, G.G.; Liu, H. Different O2-sensing mechanisms by different K+ channels. Adv. Exp. Med. Biol., 2000, 475, 441-452.
242. 2+ overload during hypoxia-reoxygenation in rat ventricular myocytes. J. Physiol., 2003, 550, 889-898.
243. Cobbold, P.H.; Bourne, P.K. Aequorin measurements of free calcium in single heart cells. Nature, 1984, 312, 444-446. (Pubitemid 15217836)
244. Lee, J.A.; Allen, D.G. Changes in intracellular free calcium concentration during long exposures to simulated ischemia in isolated mammalian ventricular muscle. Circ. Res., 1992, 71, 58-69.
245. Zucchi, R.; Ronca, F.; Ronca-Testoni, S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol. Ther., 2001, 89, 47-65. (Pubitemid 32367883)
246. Carafoli, E. Intracellular calcium homeostasis. Annu. Rev. Biochem., 1987, 56, 395-433.
247. Coronado, R.; Morrissette, J.; Sukhareva, M.; Vaughan, D.M. Structure and function of ryanodine receptors. Am. J. Physiol., 1994, 266, C1485-1504.
248. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev., 1997, 49, 1-51.
249. Meissner, G. Molecular regulation of cardiac ryanodine receptor ion channel. Cell. Calcium., 2004, 35, 621-628. (Pubitemid 38618574)
250. 2+)in cell physiology and pathophysiology. Cell. Calcium., 2000, 28, 339-348.
251. 2+ exchange. Circ. Res., 1992, 71, 547-557.
252. Kusuoka, H.; Camilion de Hurtado, M.C.; Marban, E. Role of sodium/calcium exchange in the mechanism of myocardial stunning: protective effect of reperfusion with high sodium solution. J. Am. Coll. Cardiol., 1993, 21, 240-248. (Pubitemid 23031322)
253. Murphy, J.G.; Marsh, J.D.; Smith, T.W. The role of calcium in ischemic myocardial injury. Circulation, 1987, 75, V15-24.
254. Nayler, W.G. The calcium antagonist drugs. Med. J. Aust., 1988, 149, 682-686.
255. Opie, L.H. Myocardial stunning - are calcium antagonists useful? Cardiovasc. Drugs Ther., 1994, 8(Suppl 3), 533-541. (Pubitemid 24347238)
256. Zucchi, R.; Ghelardoni, S.; Evangelista, S. Biochemical basis of ischemic heart injury and of cardioprotective interventions. Curr. Med. Chem., 2007, 14, 1619-1637. (Pubitemid 47010152)
257. Chien, K.R.; Peau, R.G.; Farber, J.L. Ischemic myocardial cell injury: prevention by chlorpromazine of an accelerated phospholipid degradation and associated membrane dysfunction. Am. J. Pathol., 1979, 97, 505-529.
258. Farber, J.L.; Chien, K.R.; Mittnacht, S.; Jr. Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia. Am. J. Pathol., 1981, 102, 271-281.
259. Pontremoli, S.; Melloni, E. Extralysosomal protein degradation. Annu. Rev. Biochem., 1986, 55, 455-481.
260. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J. Clin. Invest., 1987, 79, 950-961.
261. Carrozza, J.P.; Jr.; Bentivegna, L.A.; Williams, C.P.; Kuntz, R.E.; Grossman, W.; Morgan, J.P. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ. Res., 1992, 71, 1334-1340.
262. Gao, W.D.; Atar, D.; Liu, Y.; Perez, N.G.; Murphy, A.M.; Marban, E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ. Res., 1997, 80, 393-399. (Pubitemid 27093354)
263. Bourdillon, P.D.; Poole-Wilson, P.A. Effects of ischaemia and reperfusion on calcium exchange and mechanical function in isolated rabbit myocardium. Cardiovasc. Res., 1981, 15, 121-130.
264. Poole-Wilson, P.A.; Harding, D.P.; Bourdillon, P.D.; Tones, M.A. Calcium out of control. J. Mol. Cell Cardiol., 1984, 16, 175-187.
265. Schumacher, C.A.; Baartscheer, A.; Coronel, R.; Fiolet, J.W. Energy-dependent transport of calcium to the extracellular space during acute ischemia of the rat heart. J. Mol. Cell. Cardiol., 1998, 30, 1631-1642.
266. Ruigrok, T.J.; Burgersdijk, F.J.; Zimmerman, A.N. The calcium paradox: a reaffirmation. Eur. J. Cardiol., 1975, 3, 59-63.
267. Greve, G.; Rotevatn, S.; Saetersdal, T.; Oksendal, A.N.; Jynge, P. Ultrastructural studies of intercalated disc separations in the rat heart during the calcium paradox. Res. Exp. Med. (Berl.), 1985, 185, 195-206.
268. Oksendal, A.N.; Jynge, P.; Sellevold, O.F.; Rotevatn, S.; Saetersdal, T. The calcium paradox phenomenon: a flow rate and volume response study of calcium-free perfusion. J. Mol. Cell. Cardiol., 1985, 17, 959-972.
269. Piper, H.M. The calcium paradox revisited: an artefact of great heuristic value. Cardiovasc. Res., 2000, 45, 123-127.
270. Goldhaber, S.Z. Pulmonary embolism thrombolysis: broadening the paradigm for its administration. Circulation, 1997, 96, 716-718.
271. Ferrari, R.; Ceconi, C.; Curello, S.; Guarnieri, C.; Caldarera, C.M.; Albertini, A.; Visioli, O. Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. J. Mol. Cell. Cardiol., 1985, 17, 937-945.
272. Shlafer, M.; Myers, C.L.; Adkins, S. Mitochondrial hydrogen peroxide generation and activities of glutathione peroxidase and superoxide dismutase following global ischemia. J. Mol. Cell. Cardiol., 1987, 19, 1195-1206. (Pubitemid 18068093)
273. McCord, J.M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science, 1974, 185, 529-531.
274. Rowe, G.T.; Eaton, L.R.; Hess, M.L. Neutrophil-derived, oxygen free radical-mediated cardiovascular dysfunction. J. Mol. Cell. Cardiol., 1984, 16, 1075-1079.
275. Barrington, P.L.; Meier, C.F.; Jr.; Weglicki, W.B. Abnormal electrical activity induced by free radical generating systems in isolated cardiocytes. J. Mol. Cell. Cardiol., 1988, 20, 1163-1178.
276. Matsuura, H.; Shattock, M.J. Membrane potential fluctuations and transient inward currents induced by reactive oxygen intermediates in isolated rabbit ventricular cells. Circ. Res., 1991, 68, 319-329.
277. Coetzee, W.A.; Ichikawa, H.; Hearse, D.J. Oxidant stress inhibits Na-Ca-exchange current in cardiac myocytes: mediation by sulfhydryl groups? Am. J. Physiol., 1994, 266, H909-919.
278. 2+ exchange in ventricular myocytes. Am. J. Physiol., 1996, 271, H823-833.
279. 2+ currents in cells that survived in the epicardial border zone of canine healed infarcted heart. Am. J. Physiol. Heart Circ. Physiol., 2004, 287, H1046-1054.
280. 2+ currents in myocytes surviving in the epicardial border zone of the 5-day infarcted canine heart. Circ. Res., 1995, 77, 1180-1191.
281. Kim, Y.K.; Kim, S.J.; Kramer, C.M.; Yatani, A.; Takagi, G.; Mankad, S.; Szigeti, G.P.; Singh, D.; Bishop, S.P.; Shannon, R.P.; Vatner, D.E.; Vatner, S.F. Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial infarction. J. Mol. Cell. Cardiol., 2002, 34, 63-73.
282. Licata, A.; Aggarwal, R.; Robinson, R.B.; Boyden, P. Frequency dependent effects on Cai transients and cell shortening in myocytes that survive in the infarcted heart. Cardiovasc. Res., 1997, 33, 341-350. (Pubitemid 27072639)
283. Pu, J.; Robinson, R.B.; Boyden, P.A. Abnormalities in Ca(i)handling in myocytes that survive in the infarcted heart are not just due to alterations in repolarization. J. Mol. Cell. Cardiol., 2000, 32, 1509-1523.
284. Boyden, P.A.; Pinto, J.M. Reduced calcium currents in subendocardial Purkinje myocytes that survive in the 24- and 48-hour infarcted heart. Circulation, 1994, 89, 2747-2759.
285. 2+ transients in arrhythmogenic Purkinje cells that survive in the infarcted canine heart. Cardiovasc. Res., 2003, 57, 681-693.
286. de Bakker, J.M.; van Capelle, F.J.; Janse, M.J.; Wilde, A.A.; Coronel, R.; Becker, A.E.; Dingemans, K.P.; van Hemel, N.M.; Hauer, R.N. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation, 1988, 77, 589-606.
287. Jia, Y.; Takimoto, K. GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K(+) channel gene in cardiac myocytes and PC12 cells. Cardiovasc. Res., 2003, 60, 278-287.
288. Qin, D.; Zhang, Z.H.; Caref, E.B.; Boutjdir, M.; Jain, P.; El-Sherif, N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ. Res., 1996, 79, 461-473.
289. 2+ exchanger. Am. J. Physiol., 1999, 276, H1868-1876.
290. 2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovasc. Res., 2001, 51, 241-250.
291. 2+ exchanger, on myocardial stunning in anesthetized dogs. Eur. J. Pharmacol., 2004, 505, 163-168.
292. 2+ overload in ischemic-reperfused rat hearts. Circ. J., 2002, 66, 390-396.
293. 2+ exchanger inhibitors SEA0400 and KB-R7943. Am. J. Physiol. Heart Circ. Physiol., 2003, 284, H903-910.
294. Hotta, Y.; Nagatsu, A.; Liu, W.; Muto, T.; Narumiya, C.; Lu, X.; Yajima, M.; Ishikawa, N.; Miyazeki, K.; Kawai, N.; Mizukami, H.; Sakakibara, J. Protective effects of antioxidative serotonin derivatives isolated from safflower against postischemic myocardial dysfunction. Mol. Cell. Biochem., 2002, 238, 151-162. (Pubitemid 35023538)
295. 2+) exchanger, on myocardial ischemia-reperfusion injury in rats. J. Pharmacol. Sci., 2004, 95, 196-202.
296. 2+ exchanger inhibitors in ischaemic/ reperfused rat hearts. Br. J. Pharmacol., 2007, 151, 963-978.
297. Bolli, R.; Marban, E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev., 1999, 79, 609-634.
298. 2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning. Eur. J. Pharmacol., 2007, 572, 1-11.
299. 2+ exchanger, on stunned myocardium in anesthetized dogs. J. Anesth., 2005, 19, 124-130.
300. 2+ exchanger in the cardioprotection of metabolic inhibition preconditioning in rat ventricular myocytes. Eur. J. Pharmacol., 2007, 561, 14-22.
301. O'Rourke, B. The ins and outs of calcium in heart failure. Circ. Res., 2008, 102, 1301-1303.
302. 2+ exchange inhibitors: potential drugs to mitigate the severity of ischemic injury. Mol. Pharmacol., 2004, 66, 8-10.
303. 2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc. Hematol. Disord. Drug Targets, 2007, 7, 188-198.
304. 2+ exchange during anoxia/reoxygenation in ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol., 2001, 281, H2184-2190.
305. 2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female,
306. 2+ exchanger. J. Pharmacol. Exp. Ther., 2003, 304, 284-293.
307. 2+ exchanger gene and splicing isoforms in mice. DNA Seq., 2000, 11, 75-81.
308. 2+ exchanger knockout mouse model. Biochem. Biophys. Res. Commun., 2004, 314, 849-853.